-
NY State Department of Health Warns the Public in Central New York About Alarming Increase In Opioid Overdoses
Providers and Public Encouraged to Take Advantage of New Standing Order, Allowing New Yorkers to Get Naloxone Without a Prescription On August 26, 2022, The New York State Department of Health has been made aware of a rapid increase in opioid-related overdoses in the Central New York region....
-
Percentage of Overdose Deaths Involving Methadone Declined Between January 2019 and August 2021
National data indicate COVID-era treatment expansion was not associated with harms, add evidence to support take-home treatment for opioid use disorder The percentage of methadone-involved overdose deaths relative to all drug overdose deaths declined from January 2019 to August 2021, according...
-
The Department of Health and Human Services Announces Funding for Substance Use Treatment and Prevention Programs
The Department of Health and Human Services (HHS), through the Substance Abuse and Mental Health Services Administration (SAMHSA), is announcing two grant programs totaling $25.6 million that will expand access to medication-assisted treatment for opioid use disorder and prevent the misuse of...
-
NIH Research Matters – Treatment for Opioid Use Disorder in Jail Reduces Risk of Return
Almost two-thirds of people currently incarcerated in the U.S. have a substance use disorder. Many struggle with opioid addiction. Opioids include prescription pain relievers, heroin, and powerful synthetic versions such as fentanyl that are driving record numbers of overdose deaths. Medications...
-
Offering Buprenorphine Medication to People with Opioid Use Disorder in Jail May Reduce Rearrest and Reconviction
A study conducted in two rural Massachusetts jails found that people with opioid use disorder who were incarcerated and received a medication approved to treat opioid use disorder, known as buprenorphine, were less likely to face rearrest and reconviction after release than those who did not...
-
Buprenorphine Misuse Decreased Among U.S. Adults with Opioid Use Disorder From 2015-2019
Data from a nationally representative survey indicate that in 2019, nearly three-fourths of U.S. adults reporting buprenorphine use did not misuse the medication in the past 12 months. In addition, buprenorphine misuse among people with opioid use disorder trended downward between 2015-2019,...
